Optimization of â-Peptide Hairpin Stability
J. Am. Chem. Soc., Vol. 122, No. 17, 2000 4003
and 9.4 min. After each type of resolution, optical purity of each
enantiomer g99% (i.e., g98% e.e.).
mL) and cooled to 0 °C. To this solution were added Et3N (0.11 mL,
0.80 mmol) and acetic anhydride (47 mL, 0.46 mmol). After stirring
for 15 h at room temperature, the solution was concentrated under
reduced pressure. The residue was purified by silica chromatography
(EtOAc:MeOH ) 2:1), yielding 6 (0.12 g, 68%) as a white solid: mp
Boc-(R)-Nip-(S)-Nip-OCH3. (S)-Nip-OCH3 was prepared from
S-nipecotic acid (1R)-(+)-10-camphorsulfonic acid salt with SOCl2 in
MeOH. Boc-(R)-Nip-OH (1.72 g, 7.5 mmol), (S)-Nip-OCH3 (7.5 mmol),
and HOBt (1.22 g, 9 mmol) were dissolved in DMF (100 mL). The
solution was cooled to -15 °C, and Et3N (3.13 mL, 22.5 mmol) and
EDC (1.73 g, 9 mmol) were added. After stirring for 40 h at room
temp, the solution was concentrated under reduced pressure. The residue
was dissolved in EtOAc and washed with 1 N HCl, saturated NaHCO3,
and brine. The organic extract was dried over MgSO4 and concentrated.
The crude product was purified by silica chromatography (hexanes:
EtOAc ) 1:1), yielding Boc-(R)-Nip-(S)-Nip-OCH3 (2.58 g, 97%) as
a white solid: mp (recrystallized from 1:5 EtOAc:hexane) 86.5-88
1
(recrystallized from 10:1:70 EtOAc:MeOH:hexane) 155-157 °C; H
NMR (CD2Cl2, 500 MHz) δ 7.87 (br s), 7.49 (br s), 5.84 (br s), 4.64
(d, J ) 13.0 Hz), 4.54 (d, J ) 11.5 Hz), 4.14 (d, J ) 13.0 Hz), 3.83
(d, J ) 16.0 Hz), 3.61-3.38 (m), 3.29 (m), 3.04 (td, d ) 12.1, 6.0
Hz), 2.97 (t, J ) 12.7 Hz), 2.74 (d, J ) 5.0 Hz), 2.64-2.57 (m), 2.55
(m), 2.49 (m), 2.45 (m), 2.37 (m), 1.95-1.72 (m), 1.54 (s), 1.48-1.26
(m); EI-MS m/z (M+) calcd for C21H35O5N5 437.2638, obsd 437.2644;
IR (CH2Cl2) 3453, 3342, 1662, 1633, 1530 cm-1. Crystals of 7 suitable
for X-ray analysis were grown from a solution of CH2Cl2-MeOH-
hexane.
1
°C. H NMR (CD2Cl2) δ 4.50 (br d), 4.02 (br d), 3.78 (br t), 3.66 (s),
3.42 (m), 3.09-2.94 (m), 2.81 (m), 2.66 (m), 2.56-2.52 (m), 2.05 (m),
1.81 (m), 1.65 (m), 1.44 (s); [R]D ) +23.0 (c 1.20, CHCl3); EI-MS
m/z (M+) calcd for C18H30O5N2 354.2155, obsd 354.2151.
Ac-â-Ala-(R)-Nip-(R)-Nip-ââ-Ala-NHCH3 (7). The compound was
synthesized by a route similar to that used for 6. 1H NMR (CD2Cl2) δ
6.58 (br d), 6.42 (br d), 6.18 (br d), 4.43 (br t), 4.09 (br d), 3.67 (m),
3.46 (m), 3.21 (m), 3.04 (m), 2.85 (m), 2.74 (d, J ) 4.2 Hz), 2.58 (m),
2.48 (m), 2.35 (m), 1.89 (s), 1.86-1.44 (m); EI-MS m/z (M+) calcd
for C21H35O5N5 437.2638, obsd 437.2627; IR (CH2Cl2) 3338, 1668,
Boc-(R)-Nip-(S)-Nip-OH. To a 0 °C solution of Boc-(R)-Nip-(S)-
Nip-OCH3 (1.55 g, 4.37 mmol) in THF (20 mL) was added dropwise
a solution of LiOH‚H2O (0.19 g, 4.6 mmol) in H2O (10 mL). After 4
h at room temp, the solution was concentrated, diluted with H2O, and
extracted with Et2O. The aqueous layer was acidified to pH 2-3 with
1 N HCl. The solution was extracted with EtOAc, and the organic layer
was dried over MgSO4, concentrated, and dried under vacuum to afford
Boc-(R)-Nip-(S)-Nip-OH (1.45 g, 97%) as a white solid: mp (recrystal-
1634, 1515 cm-1
.
Tetra-â-peptides 1-4 were prepared by routes similar to that
described above for 6 (â-amino acids were coupled by using EDC and
HOBt in DMF). Synthesis of the terminal â-amino acid residues
common to 1-4 has been previously described in detail (ref 30 and
Supporting Information for ref 6a).
1
lized from 1:10 EtOAc:hexane) 166-167 °C; H NMR (CD2Cl2) δ
9.55 (br), 4.44 (br d), 4.05 (br d), 3.83 (m), 3.40 (m), 3.14 (br t), 2.93
(m), 2.84-2.56 (m), 2.45 (m), 2.10 (m), 1.83 (m), 1.66 (m), 1.43 (s);
[R]D ) +17.4 (c 1.08, CHCl3); EI-MS m/z (M+) calcd For C17H28O5N2
340.1998, obsd 340.1998.
Tetra-â-peptide 1: mp (recrystallized from 1:7 CHCl3:heptane)
1
214.5-217 °C; H NMR (CD2Cl2, 500 MHz) δ 7.70 (d, J ) 9.5 Hz),
7.49(d, J ) 4.8 Hz), 7.38-7.15 (m), 5.80 (d, J ) 10.5 Hz), 4.86 (m),
4.64 (d, J ) 13.0 Hz), 4.57 (d, J ) 12.5 Hz), 4.29 (d, J ) 12.5 Hz),
4.05 (m), 3.52 (d, J ) 11.5 Hz), 3.29 (dd, J ) 17.5, 8.0 Hz), 3.17 (d,
J ) 14.0 Hz), 3.09 (t, J ) 17.5, 12.5 Hz), 2.96 (dd, J ) 19.5, 7.8 Hz),
2.90 (d, J ) 8.0 Hz), 2.74 (d, J ) 7.8 Hz), 2.72 (m), 2.54 (m), 2.40
(td, d ) 13.0, 4.3 Hz), 2.28 (t, J ) 12.0 Hz), 2.19 (t, J ) 11.5 Hz),
1.99 (m), 1.92 (s), 1.89 m), 1.76 (d, J ) 13.5 Hz), 1.70-1.60 (m),
1.53-1.26 (m), 1.15 (m), 1.14 (d, J ) 6.1 Hz), 0.93 (t, J ) 7.3 Hz),
-0.52 (m); FAB-MS m/z (M+ + Na) calcd for C38H53N5O5SNa 714.9,
obsd 714.3; IR (CH2Cl2) 3421, 3373, 3333, 1668, 1635, 1615, 1538
Boc-(R)-Nip-(S)-Nip-â-Ala-NHCH3. Boc-(R)-Nip-(S)-Nip-OH (0.50
g, 1.46 mmol), â-alanine N-methylamide hydrochloride (0.27 g, 2.0
mmol) and HOBt (0.27 g, 2.05 mmol) were dissolved in DMF (25
mL). The solution was cooled to -15 °C, and Et3N (0.6 mL, 3.60 mmol)
and EDC (0.39 g, 2.05 mmol) were added. After stirring for 36 h at
room temperature, the solution was concentrated under reduced pressure.
The residue was dissolved in CH2Cl2 and washed with 1 N HCl,
saturated NaHCO3 and brine. The organic extract was dried over Na2-
SO4 and concentrated. The crude product was purified by silica
chromatography (EtOAc:MeOH ) 30:4), yielding Boc-(R)-Nip-(S)-
Nip-â-Ala-NHCH3 (0.57 g, 94%) as a white solid: mp (recrystallized
cm-1
.
Tetra-â-peptide 2: mp 136-140.5 °C; 1H NMR (CD2Cl2, 500
MHz) δ 7.41 (d, J ) 8.5 Hz, with minor rotamer at 7.21), 7.36-7.10
(m), 6.80 (d, J ) 9.8 Hz, with minor rotamer at 7.32), 5.81 (d, J )
10.0 Hz, with minor rotamer at 6.20), 4.85 (m), 4.63 (d, J ) 13.0 Hz),
4.55 (d, J ) 13.5 Hz), 4.12 (m), 3.68 (d, J ) 10.5 Hz), 3.41 (m), 3.25
(m), 3.04 (m), 2.97-2.87 (m), 2.76 (d), 2.73 (m), 2.48-2.27 (m), 2.12
(t, J ) 12.3 Hz), 1.94 (m), 1.85-1.62 (m), 1.55 (s), 1.40 (m), 1.26
(m), 1.05 (d), 0.95 (t, J ) 8.3 Hz), 0.87 (m); FAB-MS m/z (M+ + Na)
calcd for C38H53N5O5SNa 714.9, obsd 714.0; IR (CH2Cl2) 3425, 3357,
1
from 1:1 EtOAc:hexane) 203-205 °C; H NMR (CDCl3) δ 7.43 (br,
with minor rotamer at 6.67), 6.39 (br, with minor rotamer at 6.09),
4.56 (m), 4.22-3.99 (m), 3.69 (m), 3.66-3.43 (m), 3.30 (m), 3.08 (m),
2.79 (t), 2.68 (m), 2.47 (m), 2.35 (t), 2.28 (m), 1.95-1.68 (m), 1.47
(s); FAB-MS m/z (M+ + Na) calcd for C21H36N4O5Na 447.5, obsd
447.7.
Boc-â-Ala-(R)-Nip-(S)-Nip-â-Ala-NHCH3. Boc-(R)-Nip-(S)-Nip-
â-Ala-NHCH3 (0.28 g, 0.66 mmol) was dissolved in 4 N HCl in dioxane
(2.5 mL). After 2 h, the solvent was removed by a stream of N2, and
the residue was dried under vacuum. The resulting solid (HN-(R)-
Nip-(S)-Nip-â-Ala-NHCH3‚HCl), Boc-â-alanine (0.19 g, 0.98 mmol)
and HOBt (0.12 g, 0.92 mmol) were dissolved in DMF (10 mL). The
solution was cooled to -15 °C, and NMM (0.18 mL, 1.58 mmol) and
EDC (0.17 g, 0.92 mmol) were added. After stirring for 36 h at room
temperature, the solution was concentrated under reduced pressure. The
residue was dissolved in CH2Cl2 and washed with 1 N HCl, saturated
NaHCO3 and brine. The organic layer was dried over Na2SO4 and
concentrated. The crude product was purified by silica chromatography
(EtOAc:MeOH ) 6:1), yielding Boc-â-Ala-(R)-Nip-(S)-Nip-â-Ala-
NHCH3 (0.31 g, 96%) as an oil. 1H NMR (CDCl3) δ 7.78 (br s), 6.15
(br s), 6.09 (br s), 4.62 (m), 4.11 (m), 3.8 (m), 3.69-3.49 (m), 3.38
(m), 3.03 (m), 2.77 (d, J ) 4.5 Hz), 2.61-2.43 (m), 1.89-1.72 (m),
1.42 (s); EI-MS m/z (M+) calcd for C24H41O6N5 495.3057, obsd
495.3049.
3355, 1668, 1635, 1615, 1533 cm-1
.
Tetra-â-peptide 3: mp 132-136 °C; 1H NMR (CD2Cl2, 500 MHz)
δ 7.34-7.12 (m), 5.90 (d, J ) 9.0 Hz, with minor rotamers at 6.86
and 5.70), 6.14 (br, with minor rotamers at 6.49 and 6.43), 6.15 (br,
with minor rotamers at 6.42 and 5.84), 4.56 (m), 4.27 (m), 4.21 (d, J
) 12.0 Hz), 3.95 (m), 3.85 (m), 3.47-3.34 (m), 3.29-3.14 (m), 2.96-
2.73 (m), 2.67 (s), 2.61 (br d), 2.37-2.14 (m), 2.12-2.06 (m), 2.04
(m), 1.86 (s), 1.81-1.58 (m), 1.53 (s), 1.50 (m), 1.40 (m), 1.29 (m),
1.27-1.09 (m), 1.07 (d, J ) 13.5 Hz), 0.95-0.85 (m); FAB-MS m/z
(M+ + Na) calcd for C38H53N5O5SNa 714.9, obsd 714.0; IR (CH2Cl2)
3454, 3425, 3378, 3337, 1672, 1629, 1510 cm-1
.
Tetra-â-peptide 4: mp 138-142 °C; 1H NMR (CD2Cl2, 500 MHz)
δ 7.31-7.10 (m), 6.45 (br t, with minor rotamers at 6.22 and 6.12),
5.73 (br, with minor rotamers at 6.08 and 5.69), 5.88 (br, with minor
rotamer at 6.42), 4.52 (d, J ) 13.0 Hz),), 4.31 (m), 3.95-3.84 (m),
3.59-3.43 (m), 3.37-3.01 (m), 2.98-2.87 (m), 2.78 (m), 2.74 (d, J )
7.2 Hz), 2.4 (m), 2.32 (m), 2.19 (m), 1.98 (m), 1.86 (d, J ) 6.5 Hz),
1.71 (m), 1.58-1.43 (m), 1.32 (m), 1.10 (d, J ) 7.0 Hz), 0.96 (m),
0.89 (m); FAB-MS m/z (M+ + Na) calcd for C38H53N5O5SNa 714.9,
obsd 714.3; IR (CH2Cl2) 3455, 3425, 3338, 1676, 1629, 1549, 1510
Ac-â-Ala-(R)-Nip-(S)-Nip-â-Ala-NHCH3 (6). Boc-â-Ala-(R)-Nip-
(S)-Nip-â-Ala-NHCH3 (0.20 g, 0.40 mmol) was dissolved in 4 N HCl
in dioxane (2 mL). After 2 h, the solvent was removed under a stream
of N2, and the residue was dried under vacuum. This residue (H2N-â-
Ala-(R)-Nip-(S)-Nip-â-Ala-NHCH3‚HCl) was dissolved in CH2Cl2 (5
cm-1
.